|Author (Person)||Grajewski, Marcin|
|Author (Corporate)||European Parliament: European Parliamentary Research Service|
|Publisher||European Parliament: European Parliamentary Research Service (EPRS), European Union|
|Series Title||EPRS Briefings|
|Series Details||PE 679.083|
|Publication Date||February 2021|
|Content Type||Blog & Commentary, Report, Research Paper|
As the latest wave of the coronavirus pandemic intensifies and some highly infectious new mutations of the virus spread, a growing number of countries have increased restrictions on travel and some lockdowns have been intensified. Whilst a series of vaccines are progressively gaining official approval, and their roll-out has started, pharmaceutical companies struggle with production capacity issues, the effectiveness of the vaccines on mutations is still uncertain, and a broader debate is opening up on the global fairness of vaccine distribution beyond the ‘first’ world.
This note offers links to recent commentaries, studies and reports from international think tanks on the coronavirus and related issues. More studies on the topics can be found in a previous edition in this series.
This EPRS Briefing is part of the series What Think Tanks are Thinking.
|Subject Tags||Public Health|